Form D · Biotechnology
Polaris Quantum Biotech, Inc.
Durham, NC · CIK 0001804907
Offering snapshot reported Aug 12, 2021 · SEC filing
- Reported sold
- $2.93M Offering amount: $3.81M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 12, 2021 | Initial | $2,929,921 | No comparison | Not reported | SEC filing |
| May 5, 2020 | Amendment | $485,000 | $235,000vs Mar 5, 2020 | 6 | SEC filing |
| Mar 5, 2020 | Initial | $125,000 | No comparison | 2 | SEC filing |
| Mar 5, 2020 | Amendment | $250,000 | $125,000vs Mar 5, 2020 | 2 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-409722
Source: Form D, filed Aug 12, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Doron Gordon | Director |
| Shahar Keinan | Director, Executive |
| William J Shipman | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
201 W Main Street Suite 205
Durham, NC, 27701
Durham, NC, 27701